Compare GLNG & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLNG | SXTC |
|---|---|---|
| Founded | 1946 | 2005 |
| Country | Bermuda | China |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 177.7M |
| IPO Year | N/A | 2019 |
| Metric | GLNG | SXTC |
|---|---|---|
| Price | $37.22 | $1.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $51.13 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 58.4K |
| Earning Date | 11-21-2023 | 08-19-2019 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | ★ 333.77 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $326,627,000.00 | $1,740,907.00 |
| Revenue This Year | $50.18 | N/A |
| Revenue Next Year | $0.91 | N/A |
| P/E Ratio | $67.46 | ★ N/A |
| Revenue Growth | ★ 19.15 | N/A |
| 52 Week Low | $29.56 | $0.95 |
| 52 Week High | $45.98 | $7.84 |
| Indicator | GLNG | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 46.81 | 60.03 |
| Support Level | $36.75 | $1.52 |
| Resistance Level | $37.77 | $1.61 |
| Average True Range (ATR) | 0.72 | 0.10 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 37.77 | 62.14 |
Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.